Literature DB >> 26158753

Minireview: Deciphering the Cellular Functions of PELP1.

Preethi Ravindranathan1, Carol A Lange1, Ganesh V Raj1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26158753      PMCID： PMC5414680          DOI： 10.1210/me.2015-1049

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN： 0888-8809


× No keyword cloud information.
  52 in total

1.  Central role for PELP1 in nonandrogenic activation of the androgen receptor in prostate cancer.

Authors:  Lin Yang; Preethi Ravindranathan; Meera Ramanan; Payal Kapur; Stephen R Hammes; Jer-Tsong Hsieh; Ganesh V Raj
Journal:  Mol Endocrinol       Date:  2012-03-08

2.  The LxxLL motif: a multifunctional binding sequence in transcriptional regulation.

Authors:  Michael J Plevin; Morgon M Mills; Mitsuhiko Ikura
Journal:  Trends Biochem Sci       Date:  2005-02       Impact factor: 13.807

Review 3.  The clinical relevance of steroid hormone receptor corepressors.

Authors:  Rakesh Kumar; Anupama E Gururaj; Ratna K Vadlamudi; Suresh K Rayala
Journal:  Clin Cancer Res       Date:  2005-04-15       Impact factor: 12.531

Review 4.  Scaffolding proteins mediating membrane-initiated extra-nuclear actions of estrogen receptor.

Authors:  Viroj Boonyaratanakornkit
Journal:  Steroids       Date:  2011-02-25       Impact factor: 2.668

5.  Significance of PELP1 in ER-negative breast cancer metastasis.

Authors:  Sudipa Roy; Dimple Chakravarty; Valerie Cortez; Keya De Mukhopadhyay; Abhik Bandyopadhyay; Jung-Mo Ahn; Ganesh V Raj; Rajeshwar R Tekmal; LuZhe Sun; Ratna K Vadlamudi
Journal:  Mol Cancer Res       Date:  2011-11-15       Impact factor: 5.852

6.  Oncogenic potential of the nuclear receptor coregulator proline-, glutamic acid-, leucine-rich protein 1/modulator of the nongenomic actions of the estrogen receptor.

Authors:  Rajib Rajhans; Sujit Nair; Alan H Holden; Rakesh Kumar; Rajeshwar Rao Tekmal; Ratna K Vadlamudi
Journal:  Cancer Res       Date:  2007-06-01       Impact factor: 12.701

7.  Targeting the PELP1-KDM1 axis as a potential therapeutic strategy for breast cancer.

Authors:  Valerie Cortez; Monica Mann; Seshidhar Tekmal; Takayoshi Suzuki; Naoki Miyata; Cristian Rodriguez-Aguayo; Gabriel Lopez-Berestein; Anil K Sood; Ratna K Vadlamudi
Journal:  Breast Cancer Res       Date:  2012-07-19       Impact factor: 6.466

8.  The prognostic significance of PELP1 expression in invasive breast cancer with emphasis on the ER-positive luminal-like subtype.

Authors:  Hany Onsy Habashy; Desmond G Powe; Emad A Rakha; Graham Ball; R Douglas Macmillan; Andrew R Green; Ian O Ellis
Journal:  Breast Cancer Res Treat       Date:  2009-06-03       Impact factor: 4.872

9.  Significance of PELP1/HDAC2/miR-200 regulatory network in EMT and metastasis of breast cancer.

Authors:  S S Roy; V K Gonugunta; A Bandyopadhyay; M K Rao; G J Goodall; L-Z Sun; R R Tekmal; R K Vadlamudi
Journal:  Oncogene       Date:  2013-08-26       Impact factor: 9.867

10.  Progesterone receptor-B enhances estrogen responsiveness of breast cancer cells via scaffolding PELP1- and estrogen receptor-containing transcription complexes.

Authors:  A R Daniel; A L Gaviglio; T P Knutson; J H Ostrander; A B D'Assoro; P Ravindranathan; Y Peng; G V Raj; D Yee; C A Lange
Journal:  Oncogene       Date:  2014-01-27       Impact factor: 9.867
View more
  8 in total

1.  PELP1 signaling contributes to medulloblastoma progression by regulating the NF-κB pathway.

Authors:  Yiliao Luo; Mengxing Li; Uday P Pratap; Suryavathi Viswanadhapalli; Junhao Liu; Prabhakar P Venkata; Kristin A Altwegg; Bridgitte E Palacios; Xiaonan Li; Yihong Chen; Manjeet K Rao; Andrew J Brenner; Gangadhara R Sareddy; Ratna K Vadlamudi
Journal:  Mol Carcinog       Date:  2019-12-24       Impact factor: 4.784

Review 2.  PELP1: a key mediator of oestrogen signalling and actions in the brain.

Authors:  R Thakkar; G R Sareddy; Q Zhang; R Wang; R K Vadlamudi; D Brann
Journal:  J Neuroendocrinol       Date:  2018-02       Impact factor: 3.627

3.  Role of estrogen receptor coregulators in endocrine resistant breast cancer.

Authors:  Kristin A Altwegg; Ratna K Vadlamudi
Journal:  Explor Target Antitumor Ther       Date:  2021-08-30

Review 4.  PELP1: Structure, biological function and clinical significance.

Authors:  Gangadhara Reddy Sareddy; Ratna K Vadlamudi
Journal:  Gene       Date:  2016-03-18       Impact factor: 3.688

5.  Breast Tumor Kinase (Brk/PTK6) Is Induced by HIF, Glucocorticoid Receptor, and PELP1-Mediated Stress Signaling in Triple-Negative Breast Cancer.

Authors:  Tarah M Regan Anderson; Shi Hong Ma; Ganesh V Raj; John A Cidlowski; Taylor M Helle; Todd P Knutson; Raisa I Krutilina; Tiffany N Seagroves; Carol A Lange
Journal:  Cancer Res       Date:  2016-01-29       Impact factor: 12.701

6.  PELP1 promotes glioblastoma progression by enhancing Wnt/β-catenin signaling.

Authors:  Gangadhara R Sareddy; Uday P Pratap; Suryavathi Viswanadhapalli; Prabhakar Pitta Venkata; Binoj C Nair; Samaya Rajeshwari Krishnan; Siyuan Zheng; Andrea R Gilbert; Andrew J Brenner; Darrell W Brann; Ratna K Vadlamudi
Journal:  Neurooncol Adv       Date:  2019-11-05

7.  Interaction of transcription factor AP-2 gamma with proto-oncogene PELP1 promotes tumorigenesis by enhancing RET signaling.

Authors:  Junhao Liu; Zexuan Liu; Mengxing Li; Weiwei Tang; Uday P Pratap; Yiliao Luo; Kristin A Altwegg; Xiaonan Li; Yi Zou; Hong Zhu; Gangadhara R Sareddy; Suryavathi Viswanadhapalli; Ratna K Vadlamudi
Journal:  Mol Oncol       Date:  2021-02-09       Impact factor: 6.603

8.  Global Genomic and Proteomic Analysis Identified Critical Pathways Modulated by Proto-Oncogene PELP1 in TNBC.

Authors:  Zexuan Liu; Kristin A Altwegg; Junhao Liu; Susan T Weintraub; Yidong Chen; Zhao Lai; Gangadhara R Sareddy; Suryavathi Viswanadhapalli; Ratna K Vadlamudi
Journal:  Cancers (Basel)       Date:  2022-02-13       Impact factor: 6.575
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.